Senior Leadership
高层领导
基本信息
- 批准号:8719585
- 负责人:
- 金额:$ 2.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-30 至 2017-01-31
- 项目状态:已结题
- 来源:
- 关键词:AreaBasic ScienceCancer CenterCancer Center Support GrantClinical ResearchCollaborationsConsensusCounselingDoctor of PhilosophyEnsureFoxesFundingInstructionLaboratory ResearchLeadershipRecommendationResearchResearch InfrastructureResource AllocationResource SharingResourcesRoleStrategic PlanningUniversitiesUniversity of Virginia Cancer CenterVirginiaVisionauthoritybasemeetingsmemberprograms
项目摘要
The University of Virginia (UVA) Cancer Center is directed by Michael J. Weber, PhD. He is assisted in this
role by the Senior Leadership team comprised of: Paula M. Fracasso, MD, PhD (Deputy Director and
Associate Director for Clinical Research), Jay W. Fox, PhD (Associate Director for Laboratory Research
Infrastructure), Dina G. Halme, PhD (Associate Director for Research Administration), Christopher A.
Moskaluk, MD, PhD (Associate Director for Translational Infrastructure), and Sarah J. Parsons, PhD
(Associate Director for Laboratory Research).
Members of the Senior Leadership each possess a different area of responsibility, perspective, and
expertise. Together they form a strong center to the matrix that is the UVA Cancer Center. Dr. Weber and
the Senior Leadership use consensus building in interacting with UVA departments and committees and with
the Program Leaders to formulate priorities, develop strategic plans, and allocate resources. They provide
recommendations on integrating research between the Programs, discuss collaborations and discoveries
within the Programs, assist in oversight of the Shared Resources, and help identify synergies in basic and
clinical research and in infrastructure. Collectively, they ensure that the allocation of resources is aligned with
the strategic vision of the Cancer Center.
A subset of the Senior Leadership team (Weber, Fracasso, Halme, and Parsons) meets weekly and the
entire team meets monthly at the CCSG Executive Committee meeting. They provide direct counsel and
recommendations to the Director based on these interactions. Final authority for decisions on behalf of the
UVA Cancer Center resides with the Director.
弗吉尼亚大学(UVA)癌症中心由Michael J. Weber博士领导。他在这方面得到协助
高级领导团队的角色,包括:Paula M. Fracasso,MD,PhD(副主任,
临床研究副总监),Jay W. Fox,PhD(实验室研究副主任
Infrastructure),Dina G. Halme博士(研究管理副主任),Christopher A.
Moskaluk,MD,PhD(翻译基础设施副总监)和Sarah J. Parsons,PhD
(实验室研究副主任)。
高级领导层成员各自拥有不同的责任领域、观点和
专业知识他们一起形成了一个强大的中心矩阵,这是UVA癌症中心。韦伯博士和
高层领导在与弗吉尼亚大学各部门和委员会以及
项目负责人制定优先事项、制定战略计划和分配资源。它们提供
关于整合项目之间研究的建议,讨论合作和发现
在计划内,协助监督共享资源,并帮助确定基本和
临床研究和基础设施。它们共同确保资源的分配符合
癌症中心的战略愿景。
高级领导团队的一部分(Weber、Fracasso、Halme和Parsons)每周召开一次会议,
整个团队每月在CCSG执行委员会会议上开会。他们提供直接咨询,
根据这些互动向主任提出建议。代表委员会作出决定的最后权力
UVA癌症中心与主任住在一起。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL J. WEBER其他文献
MICHAEL J. WEBER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL J. WEBER', 18)}}的其他基金
Adaptive signaling exposes a therapeutic vulnerability in NRAS melanomas
适应性信号传导暴露了 NRAS 黑色素瘤的治疗脆弱性
- 批准号:
8621637 - 财政年份:2014
- 资助金额:
$ 2.5万 - 项目类别:
相似海外基金
HNDS-R: Connectivity, Inclusiveness, and the Permeability of Basic Science
HNDS-R:基础科学的连通性、包容性和渗透性
- 批准号:
2318404 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Standard Grant
Advancing the basic science of membrane permeability in macrocyclic peptides
推进大环肽膜渗透性的基础科学
- 批准号:
10552484 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Computer Vision for Malaria Microscopy: Automated Detection and Classification of Plasmodium for Basic Science and Pre-Clinical Applications
用于疟疾显微镜的计算机视觉:用于基础科学和临床前应用的疟原虫自动检测和分类
- 批准号:
10576701 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Bringing together communities and basic science researchers to build stronger relationships
将社区和基础科学研究人员聚集在一起,建立更牢固的关系
- 批准号:
480914 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Miscellaneous Programs
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
- 批准号:
FL210100071 - 财政年份:2022
- 资助金额:
$ 2.5万 - 项目类别:
Australian Laureate Fellowships
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
早期病变转化和基础科学研究协调和数据管理中心
- 批准号:
10517004 - 财政年份:2022
- 资助金额:
$ 2.5万 - 项目类别:
Developing science communication on large scale basic science represented by accelerator science
发展以加速器科学为代表的大规模基础科学科学传播
- 批准号:
22K02974 - 财政年份:2022
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic Science Core - Biosafety & Biocontainment Core (BBC)
基础科学核心 - 生物安全
- 批准号:
10431468 - 财政年份:2022
- 资助金额:
$ 2.5万 - 项目类别: